A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

被引：0
|
作者：
E. Esteban
González de Sande
J. Puertas
J. Fra
I. Palacio
J.M. Vieitez
J.L. Fernández
I. Muñiz
A. Modollel
J. Carrasco
M. Sala
A.J. Lacave
机构：
来源：
Breast Cancer Research and Treatment | 2000年 / 62卷
关键词：
advanced breast cancer; vinorelbine; epirubicin; cyclophosphamide; combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background.Vinorelbine (Navelbin®; N) has proven to be active in patients with advanced breast cancer (ABC) and cyclophosphamide (C) and epirubicin (Epiadriamycin®: E) are still among the main cytostatic agents against this tumor. On this basis was carried out a study to determine the activity and toxicity of the combination of these three agents (CEN).
引用
收藏
页码：127 / 133
页数：6
相关论文
共 50 条
  • [1] A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer
    Esteban, E
    de Sande, G
    Puertas, J
    Fra, J
    Palacio, I
    Vieitez, JM
    Fernández, JL
    Muñiz, I
    Modollel, A
    Carrasco, J
    Sala, M
    Lacave, AJ
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (02) : 127 - 133
  • [2] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [3] Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer
    Ardavanis, A
    Extra, JM
    Espié, M
    Cuvier, C
    Marty, M
    IN VIVO, 1998, 12 (05): : 559 - 562
  • [4] A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer
    Garrone, O
    Principe, E
    Occelli, M
    Mercuri, M
    Numico, G
    Granetto, C
    Di Costanzo, G
    Rattazzi, PD
    Merlano, M
    ANTI-CANCER DRUGS, 2004, 15 (01) : 23 - 27
  • [5] Randomized phase II trial of adjuvant vinorelbine and epirubicin versus adriamycin and cyclophosphamide in node negative breast cancer [AViEN trial]
    Kim, K. S.
    Kang, S. Y.
    Kim, R. M.
    Jung, S. -H.
    Chung, B. W.
    Bae, J. -W.
    Shin, H. J.
    Kim, S. -Y.
    Jung, Y. S.
    Han, S. W.
    BREAST, 2011, 20 : S67 - S68
  • [6] A phase II trial of paclitaxel and epirubicin in advanced breast cancer
    Rischin, D.
    Smith, J.
    Millward, M.
    Lewis, C.
    Boyer, M.
    Richardson, G.
    Toner, G.
    Gurney, H.
    McKendrick, J.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 438 - 442
  • [7] A phase II trial of paclitaxel and epirubicin in advanced breast cancer
    D Rischin
    J Smith
    M Millward
    C Lewis
    M Boyer
    G Richardson
    G Toner
    H Gurney
    J McKendrick
    British Journal of Cancer, 2000, 83 : 438 - 442
  • [8] PHASE-II TRIAL OF HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    SCINTO, AF
    CERCATO, MC
    BOTTI, C
    TONACHELLA, R
    FERRARESI, V
    DELBIANCO, S
    SACCHI, I
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1285 - 1288
  • [9] Phase II study of neaodajuvant chemotherapy combining epirubicin cyclophosphamide and vinorelbine (NEC) in locally advanced breast cancer (LABC): Preliminary results
    Braud, AC
    Jauffret, E
    Kirova, YM
    Piedbois, P
    Levy, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S206 - S206
  • [10] Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer
    Eisen, T
    Smith, IE
    Johnston, S
    Ellis, PA
    Prendiville, J
    Seymour, MT
    Walsh, G
    Ashley, S
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1350 - 1357
12345